Organogenesis Net Debt from 2010 to 2024

ORGO Stock  USD 2.75  0.02  0.73%   
Organogenesis Holdings Net Debt yearly trend continues to be very stable with very little volatility. Net Debt is likely to grow to about 16.2 M this year. Net Debt is the total debt of Organogenesis Holdings minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals
 
Net Debt  
First Reported
2016-06-30
Previous Quarter
15 M
Current Value
26.9 M
Quarterly Volatility
25.8 M
 
Covid
Check Organogenesis Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Organogenesis main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 2.1 M or Selling General Administrative of 146.1 M, as well as many exotic indicators such as Price To Sales Ratio of 2.26, Dividend Yield of 0.0 or PTB Ratio of 1.83. Organogenesis financial statements analysis is a perfect complement when working with Organogenesis Holdings Valuation or Volatility modules.
  
This module can also supplement Organogenesis Holdings' financial leverage analysis and stock options assessment as well as various Organogenesis Holdings Technical models . Check out the analysis of Organogenesis Holdings Correlation against competitors.
To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.

Latest Organogenesis Holdings' Net Debt Growth Pattern

Below is the plot of the Net Debt of Organogenesis Holdings over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Organogenesis Holdings' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Organogenesis Holdings' overall financial position and show how it may be relating to other accounts over time.
Net Debt10 Years Trend
Slightly volatile
   Net Debt   
       Timeline  

Organogenesis Net Debt Regression Statistics

Arithmetic Mean9,926,506
Geometric Mean771,387
Coefficient Of Variation144.47
Mean Deviation11,964,518
Median48,938
Standard Deviation14,340,505
Sample Variance205.7T
Range41.5M
R-Value0.56
Mean Square Error151.9T
R-Squared0.31
Significance0.03
Slope1,796,976
Total Sum of Squares2879.1T

Organogenesis Net Debt History

202416.2 M
202315 M
202221.3 M
202118.4 M
2020377 K
201940.4 M
201838 M

Other Fundumenentals of Organogenesis Holdings

Organogenesis Holdings Net Debt component correlations

0.920.73-0.340.840.160.860.850.430.80.670.820.730.640.260.70.410.80.10.820.390.570.79
0.920.54-0.040.620.240.650.640.380.510.60.550.510.510.570.580.120.510.290.590.420.310.59
0.730.54-0.260.74-0.10.870.690.280.80.870.870.910.34-0.340.890.390.830.220.920.50.640.95
-0.34-0.04-0.26-0.540.16-0.38-0.63-0.09-0.70.13-0.55-0.49-0.60.29-0.1-0.73-0.660.79-0.440.47-0.64-0.34
0.840.620.74-0.540.350.930.930.610.910.650.90.760.72-0.140.780.640.9-0.10.870.250.770.79
0.160.24-0.10.160.350.150.150.65-0.020.22-0.02-0.140.330.320.28-0.03-0.060.160.02-0.040.18-0.03
0.860.650.87-0.380.930.150.860.520.910.790.960.860.59-0.220.830.470.930.130.960.460.630.91
0.850.640.69-0.630.930.150.860.50.890.550.850.80.84-0.050.670.630.89-0.240.80.180.670.76
0.430.380.28-0.090.610.650.520.50.360.480.390.340.420.040.590.190.410.060.370.340.280.42
0.80.510.8-0.70.91-0.020.910.890.360.550.970.840.62-0.310.660.720.98-0.220.920.210.790.83
0.670.60.870.130.650.220.790.550.480.550.660.730.3-0.140.940.170.590.470.740.70.390.8
0.820.550.87-0.550.9-0.020.960.850.390.970.660.880.55-0.330.730.550.980.00.980.330.730.92
0.730.510.91-0.490.76-0.140.860.80.340.840.730.880.58-0.320.810.40.89-0.040.880.270.570.93
0.640.510.34-0.60.720.330.590.840.420.620.30.550.580.150.410.440.6-0.390.49-0.150.390.44
0.260.57-0.340.29-0.140.32-0.22-0.050.04-0.31-0.14-0.33-0.320.15-0.19-0.3-0.330.14-0.31-0.03-0.28-0.29
0.70.580.89-0.10.780.280.830.670.590.660.940.730.810.41-0.190.30.70.280.80.510.570.86
0.410.120.39-0.730.64-0.030.470.630.190.720.170.550.40.44-0.30.30.62-0.650.440.00.670.29
0.80.510.83-0.660.9-0.060.930.890.410.980.590.980.890.6-0.330.70.62-0.150.940.250.740.89
0.10.290.220.79-0.10.160.13-0.240.06-0.220.470.0-0.04-0.390.140.28-0.65-0.150.140.62-0.230.22
0.820.590.92-0.440.870.020.960.80.370.920.740.980.880.49-0.310.80.440.940.140.370.730.96
0.390.420.50.470.25-0.040.460.180.340.210.70.330.27-0.15-0.030.510.00.250.620.37-0.060.42
0.570.310.64-0.640.770.180.630.670.280.790.390.730.570.39-0.280.570.670.74-0.230.73-0.060.65
0.790.590.95-0.340.79-0.030.910.760.420.830.80.920.930.44-0.290.860.290.890.220.960.420.65
Click cells to compare fundamentals

About Organogenesis Holdings Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Organogenesis Holdings income statement, its balance sheet, and the statement of cash flows. Organogenesis Holdings investors use historical funamental indicators, such as Organogenesis Holdings's Net Debt, to determine how well the company is positioned to perform in the future. Although Organogenesis Holdings investors may use each financial statement separately, they are all related. The changes in Organogenesis Holdings's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Organogenesis Holdings's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Organogenesis Holdings Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Organogenesis Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Debt15 M16.2 M
Net Debt To EBITDA 0.38  0.44 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Organogenesis Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organogenesis Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organogenesis Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organogenesis Holdings Stock:
Check out the analysis of Organogenesis Holdings Correlation against competitors.
To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.
Note that the Organogenesis Holdings information on this page should be used as a complementary analysis to other Organogenesis Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Organogenesis Stock analysis

When running Organogenesis Holdings' price analysis, check to measure Organogenesis Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organogenesis Holdings is operating at the current time. Most of Organogenesis Holdings' value examination focuses on studying past and present price action to predict the probability of Organogenesis Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organogenesis Holdings' price. Additionally, you may evaluate how the addition of Organogenesis Holdings to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Organogenesis Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
11.307
Earnings Share
0.04
Revenue Per Share
3.313
Quarterly Revenue Growth
0.022
Return On Assets
0.0201
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.